Effects of Nitric Oxide (NO) and Soluble Nucleoside Triphosphate Diphosphohydrolase (NTPDase) on Inhibition of Platelet Deposition In Vitro

Thrombosis Research

Volumn 102, Issue 4, 2001, Pages 331-341

  Ramamurthi, Anand ^a   Robson, Simon C ^b   Lewis, Randy S ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c Oklahoma State University   (United States)

Author keywords

Apyrase; Aspirin; Nitric oxide; NTPDase; Platelet inhibition

Indexed keywords

ACETYLSALICYLIC ACID; APYRASE; BIOMATERIAL; ICOSANOID; NITRIC OXIDE; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE; NUCLEOTIDASE; OXYGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOSIS; VASCULAR ENDOTHELIUM;

ACID ANHYDRIDE HYDROLASES; ADOLESCENT; ADULT; ASPIRIN; BLOOD PLATELETS; COLLAGEN; HUMANS; KINETICS; NITRIC OXIDE; NUCLEOSIDE-TRIPHOSPHATASE; PLATELET ADHESIVENESS; PLATELET AGGREGATION INHIBITORS; STRESS, MECHANICAL;

EID: 0035873824     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00244-4     Document Type: Article

References (37)

1. Becker BF, Heindl B, Kupatt C, Zahler S Endothelial function and hemostasis. Z Kardiol. 89(3):2000;160-167.
2. Marcus AJ, Safier LB Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis. FASEB J. 7:1993;516-522.
3. Ruggeri ZM Mechanisms of shear induced platelet adhesion and aggregation. Thromb Haemostasis. 70:1993;119-123.
4. Marcus AJ, Safier LB, Broekman MJ, Islam N, Fliessbach JH, Hajjar KA, Kaminski WE, Jendraschak E, Silverstein RL, von Schacky C Thrombosis and inflammation as multicellular processes: significance of cell-cell interactions. Thromb Haemostasis. 74(1):1995;213-217.
5. Ignarro LJ Nitric oxide-mediated vasorelaxation. Thromb Haemostasis. 70(1):1993;148-151.
6. Rao GH, Krishnamurthi S, Raij L, White JG Influence of nitric oxide on agonist-mediated calcium mobilization in platelets. Biochem Med Metab Biol. 43:1990;271-275.
7. Bassenge E Clinical relevance of endothelium-derived relaxing factor (EDRF). Br J Clin Pharmacol. 34(Suppl 1):1992;37S-42S.
8. Busse R, Fleming I, Hecker M Signal transduction in endothelium-dependent vasodilatation. Eur Heart J. 14(Suppl I):1994;2-9.
9. Kaczmarek E, Koziak K, Sevigny J, Siegel JB, Anrather J, Beaudoin AR, Bach FH, Robson SC Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem. 271(51):1996;33116-33122.
10. Coade SB, Pearson JD Metabolism of adenine nucleotides in human blood. Circ Res. 65(3):1989;531-537.
11. Gordon EL, Pearson JD, Dickinson ES, Moreau D, Slakey LL The hydrolysis of extracellular adenine nucleotides by arterial smooth muscle cells. Regulation of adenosine production at the cell surface. J Biol Chem. 264(32):1989;18986-18995.
12. Robson SC, Kaczmarek E, Siegel JB, Candinas D, Koziak K, Millan M, Hancock WW, Bach FH Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med. 185:1997;153-163.
13. Makita K, Shimoyama T, Sakurai Y, Yagi H, Matsumoto M, Narita N, Sakamoto Y, Saito S, Ikeda Y, Suzuki M, Titani K, Fujimura Y Placental ecto-ATP diphosphohydrolase: its structural feature distinct from CD39, localization and inhibition on shear-induced platelet aggregation. Int J Hematol. 68:1998;297-310.
14. Patrono C Aspirin and human platelets: from clinical trials to acetylation of cyclooxygenase and back. Trends Pharmacol Sci. 10(11):1989;453-458.
15. Larsson R, Larm O, Olsson P The search for thromboresistance using immobilized heparin. Ann NY Acad Sci. 516:1987;102-108.
16. Valles J, Aznar J, Santos T, Marcus AJ, Safier LB, Broekman MJ Effects of different doses of aspirin on 'ex-vivo' platelet recruitment. Modulatory role of erythrocytes. Thromb Haemostasis. 69(4):1993;212-218.
17. Bozzo J, Hernandez MR, Galan AM, Heras M, Ordinas A, Escolar G Impaired antiplatelet effects of aspirin associated with hypoxia and ATP release from erythrocytes. Studies in a system with flowing human blood. Eur J Clin Invest. 29(5):1999;438-444.
18. Robson SC, Sevigny J, Imai M, Guckelberger O, Enjyoji K Thromboregulatory potential of endothelial CD39/nucleoside triphosphate diphosphodyrolase: modulation of purinergic signaling in platelets. Emerging Ther Targets. 4(2):2000;1-17.
19. Provost P, Tremblay J, Merhi Y The antiadhesive and antithrombotic effects of the nitric oxide donor SIN-1 are combined with a decreased vasoconstriction in a porcine model of balloon angioplasty. Arterioscler, Thromb, Vasc Biol. 17:1997;1806-1812.
20. Broeders MAW, Tangelder G, Slaaf DW, Reneman RS, oude Egbrink MGA Endogenous nitric oxide protects against thromboembolism in venules but not arterioles. Arterioscler, Thromb, Vasc Biol. 18:1998;139-145.
21. Ramamurthi A, Lewis RS Design of a novel apparatus to study nitric oxide (NO) inhibition of platelet adhesion. Ann Biomed Eng. 26(6):1998;1036-1043.
22. Ramamurthi A, Lewis RS Design of a novel apparatus to study nitric oxide (NO) inhibition of platelet adhesion. Ann Biomed Eng. 27(3):1999;411. Erratum.
23. Ramamurthi A, Lewis RS Influence of agonist, shear rate, and perfusion time on nitric oxide inhibition of platelet deposition. Ann Biomed Eng. 28(2):2000;174-181.
24. Stamler JS, Jia L, Eu JP, McMahon TJ, Demchenko IT, Bonaventura J, Gernert K, Piantadosi CA Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science. 276(5321):1997;2034-2037.
25. 51Cr and characterization of its binding sites in human platelets. Blood. 25(5):1970;727-739.
26. Reimers HJ Adenine nucleotides in blood platelets. Longnecker GL The platelets: physiology and pharmacology. 1985;85-106 Academic Press, Orlando, FL.
27. Luthje J, Schomburg A, Ogilvie A Demonstration of a novel ecto-enzyme on human erythrocytes, capable of degrading ADP and of inhibiting ADP-induced platelet aggregation. Eur J Biochem. 175(2):1988;285-289.
28. Cazenave JP, Packham MA, Mustard JF Adherence of platelets to a collagen-coated surface: development of a qualitative method. J Lab Clin Med. 82(6):1973;978-990.
29. Baykov AA, Evtushenko OA, Avaeva SM A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay. Anal Biochem. 171:1988;266-270.
30. Geladopoulos TP, Sotiroudis TG, Avangelopoulos AE A malachite green colorimetric assay for protein phosphatase activity. Anal Biochem. 192:1991;112-116.
31. 15N) nitrate in biological fluids. Anal Biochem. 126:1982;131-138.
32. Lewis RS, Deen WM Kinetics of the reaction of nitric oxide with oxygen in aqueous solutions. Chem Res Toxicol. 7:1994;568-574.
33. Lange NA Lange's handbook of chemistry. rev. 10th ed. 1967;1101 McGraw-Hill, NY.
34. Negrescu EV, Grunberg B, Kratzer MA, Lorenz R, Siess W Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside. Cardiovasc Drugs Ther. 9:1995;619-629.
35. Fisch A, Michael-Hepp J, Meyer J, Darius H Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP. Eur J Pharmacol. 289:1995;455-461.
36. Huie RE, Padmaja S The reaction of NO with superoxide. Free Radical Res Commun. 18:1993;195-199.
37. Brown AS, Moro MA, Masse JM, Cramer EM, Radomski M, Darley-Usmar V Nitric oxide-dependent and independent effects on human platelets treated with peroxynitrite. Cardiovasc Res. 40:1998;380-388.